Abstract
Hypertension and dementia commonly co-exist in older people, yet guidance is lacking on how to manage these co-existing conditions. The aim of this systematic review was to assess the evidence for the treatment of hypertension in older people with dementia. Medline, EMBASE, Cochrane Library and the national research register archives were searched. Inclusion criteria were: randomised controlled trial of hypertension treatment, included participants aged 65+ years, participants had a diagnosis of dementia (global cognitive decline for at least 6 months affecting daily function), and the study assessed cognitive outcomes using validated tools. Dementia prevention studies and poor quality studies were excluded. The initial search revealed 1178 papers of potential interest, of which 24 were selected for review and six met the full inclusion criteria. Trials included people with mild-to-moderate but not severe dementia; exclusion criteria for the trials were extensive. Four trials were placebo-controlled RCTs; the remaining two compared different antihypertensives. All trials reported MMSE scores at baseline and follow-up; four reported blood pressure changes at follow-up; and only three reported cardiovascular morbidity or mortality at follow-up. Only one of four placebo-controlled studies showed evidence of blood pressure reduction, but no clear evidence for benefit (or harm) from antihypertensives on cognition, physical function or other cardiovascular outcomes. We found no evidence to confirm or refute the hypothesis that treatment of hypertension in people with dementia leads to overall health benefit.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Krause T, Lovibond K, Caulfield M, McCormack T, Williams B . Management of hypertension: summary of NICE guidance. BMJ 2011; 343: d4891.
Musini VM, Tejani AM, Bassett K, Wright JM . Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009; (4): CD000028.pub 2.
Beckett NSPR, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V et al. For the HYVET Study Group: treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358 (18): 1887–1898.
Law M, Morris J, Wald N . Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338 (33a): 1–19.
Barnes DE, Cauley JA, Lui LY, Fink HA, McCulloch C, Stone KL et al. Women who maintain optimal cognitive function into old age. J Am Geriatr Soc 2007; 55 (2): 259–264.
Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352 (9137): 1347–1351.
Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003; 163: 1069–1075.
Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B et al. The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization. J Hypertens Engl 2004; 22: 1605–1612.
Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008; 7: 683–689.
Di Bari M, Pahor M, Franse LV, Shorr RI, Wan JY, Ferrucci L et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol 2001; 153 (1): 72–78.
Birkenhager WH, Forette F, Staessen JA . Dementia and antihypertensive treatment. Curr Opin Nephrol Hypertens 2004; 13 (2): 225–230.
Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L . Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol 2003; 60: 223–228.
van Beek AH, Sijbesma JC, Jansen RW, Rikkert MG, Claassen JA . Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use. J Alzheimers Dis 2010; 21 (2): 519–526.
Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358 (18): 1887–1898.
Tinetti ME . Preventing falls in elderly persons. New Engl J Med 2003; 348 (1): 42–49.
Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS . Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension 1992; 19 (6 Pt 1): 508–519.
Kanemaru A, Kanemaru K, Kuwajima I . The effects of short-term blood pressure variability and nighttime blood pressure levels on cognitive function. Hypertens Res 2001; 24 (1): 19–24.
Fisher AA, Davis MW, Srikusalanukul W, Budge MM . Postprandial hypotension predicts all-cause mortality in older, low-level care residents. J Am Geriatr Soc 2005; 53 (8): 1313–1320.
Moretti R, Torre P, Antonello RM, Manganaro D, Vilotti C, Pizzolato G . Risk factors for vascular dementia: hypotension as a key point. Vasc Health Risk Manag 2008; 4 (2): 395–402.
Shah K, Qureshi SU, Johnson M, Parikh N, Schulz PE, Kunik ME . Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. Am J Geriatric Pharmacother 2009; 7 (5): 250–261.
vanTulder MW, Assendelft WJJ, Koes BW, Bouter LM . Method guidelines for systematic reviews in the Cochrane Collaboration back review group for spinal disorders. Spine 1997; 22 (20): 2323–2330.
Kume K, Hanyu H, Sakurai H, Takada Y, Onuma T, Iwamoto T . Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease. Geriatrics Gerontol Int 2012; 12: 207–214.
Ohrui T, Tomita N, Sato-Nakagawa T, Matsui T, Maruyama M, Niwa K et al. Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology 2004; 63: 1324–1325.
Morich FJ, Bieber F, Lewis JM, Kaiser L, Cutler NR, Escobar JI et al. Nimodipine in the Treatment of Probable Alzheimer's Disease. Clin Drug Invest 1996; 11 (4): 185–195.
Pantoni L, del Ser T, Soglian AG, Amigoni S, Spadari G, Binelli D et al. Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial. Stroke 2005; 36: 619–624.
Sze KH, Sim TC, Wong E, Cheng S, Woo J . Effect of nimodipine on memory after cerebral infarction. Acta Neurologica Scandinavica 1998; 97: 386–392.
Wang R, Lagakos S, Ware J, Hunter D, Drazen J . Statistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials. New Engl J Med 2007; 357 (21): 2189–2194.
Feise R . Do multiple outcome measures require P-value adjustment? BMC Med Res Methodol 2002; 2 (1): 8.
Odden MC, Peralta CA, Haan MN, Covinsky KE . Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med 2012; 172 (15): 1162–1168.
Sabayan B, Oleksik A, Maier A, van Buchem M, Poortvliet R, de Ruijter W et al. High blood pressure and resilience to physical and cognitive decline in the oldest old: The Leiden 85-Plus Study. J Am Geriatrics Soc 2012; 60: 2014–2019.
Xie J, Brayne C, Matthews FE . Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ 2008; 336: 258–262.
Gill TM, Gahbauer EA, Han L, Allore HG . Trajectories of Disability in the Last Year of Life. New Engl J Med 2010; 362 (13): 1173–1180.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Authorship
All authors conform that they are entitled to be considered as authors according to the universal requirements set out at: http://mts-jhh.nature.com/cgi-bin/main.plex?form_type=display_auth_instructions.
Author contributions
SC had the original idea, which was moulded by LB, JKH, RHH, TGR and JRFG. SC, LB, JKH undertook the literature search, analysed the papers and abstracted data; all authors contributed to writing the paper.
Supplementary Information accompanies this paper on the Journal of Human Hypertension website
Rights and permissions
About this article
Cite this article
Beishon, L., Harrison, J., Harwood, R. et al. The evidence for treating hypertension in older people with dementia: a systematic review. J Hum Hypertens 28, 283–287 (2014). https://doi.org/10.1038/jhh.2013.107
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2013.107
Keywords
This article is cited by
-
Cardiovascular drug use among people with cognitive impairment living in nursing homes in northern Sweden
European Journal of Clinical Pharmacology (2020)
-
p38 MAPK Inhibition Improves Synaptic Plasticity and Memory in Angiotensin II-dependent Hypertensive Mice
Scientific Reports (2016)
-
Hypertonie und die Folgen für kognitive Funktionsstörungen und Demenz
CardioVasc (2016)